Retrospective Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer in Two Successive Time Periods
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Female
Post Menopausal, Breast Cancer
Female
Post Menopausal, Breast Cancer
Trial Information
Retrospective Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer in Two Successive Time Periods
Inclusion Criteria:
- Post-menopausal patients with surgically treated breast cancer who started adjuvant
hormonal therapy between January 2006 and December 2006 or between January 2008 and
December 2008
- Documented evidence of the way adjuvant hormonal treatment was initiated.
Exclusion Criteria:
- Pre- or peri-menopausal patients with surgically treated breast cancer who started
adjuvant hormonal therapy
- Patients already enrolled in clinical studies aimed at investigating hormone
therapies
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Outcome Measure:
Relative frequencies of the first adjuvant hormonal treatment (tamoxifen vs aromatase inhibitor) started during two time periods of 12 months each - the years 2006 and 2008
Outcome Time Frame:
May-July 2009
Safety Issue:
Yes
Principal Investigator
Davide Meani, Dr.
Investigator Role:
Study Chair
Investigator Affiliation:
AstraZeneca S. p. A.
Authority:
Italy: Ethics Committee
Study ID:
NIS-OIT-ARI-2008/1
NCT ID:
NCT00884143
Start Date:
July 2009
Completion Date:
January 2010
Related Keywords:
- Post Menopausal
- Breast Cancer
- tamoxifen
- arimidex
- adjuvant hormonal therapies
- breast cancer
- post-menopausal
- Adjuvant hormonal therapy in patients post menopausal with breast cancer
- Breast Neoplasms
Name | Location |
|---|
